SCHEMBL6569627

SCHEMBL6569627

CC[C@]12CC[C@@H]3c4ccc(OC)cc4C[C@@H](C)[C@H]3[C@@H]1CC=C2O[Si](C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.39
STS P08842 1/20 0.38
HSD17B1 P14061 2/20 0.36
LMNA P02545 4/20 0.36
MAPT P10636 1/20 0.36
RECQL P46063 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.35
CHRNB2 P17787 1/20 0.34
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNA7 P36544 1/20 0.34
CHRNA4 P43681 1/20 0.34
ESR1 P03372 4/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
HIF1A Q16665 1/20 0.33
NR3C1 P04150 1/20 0.33
PGR P06401 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6569630 1.00 HRH3 (0.39) HRH3STSHSD17B1LMNAMAPT
SCHEMBL4370456 0.86 LMNA (0.42) HRH3STSHSD17B1LMNAMAPT
SCHEMBL5972920 0.79 LMNA (0.52) HRH3STSHSD17B1LMNAMAPT
SCHEMBL5972923 0.79 LMNA (0.52) HRH3STSHSD17B1LMNAMAPT
SCHEMBL13049215 0.78 LMNA (0.40) STSHSD17B1LMNAMAPTRECQL
SCHEMBL6570677 0.75 HSD17B1 (0.43) HRH3STSHSD17B1LMNAMAPT
SCHEMBL6570384 0.75 LMNA (0.40) HRH3STSHSD17B1LMNAMAPT
SCHEMBL6570381 0.75 LMNA (0.40) HRH3STSHSD17B1LMNAMAPT
SCHEMBL6462339 0.75 ESR1 (0.51) HRH3STSHSD17B1LMNAMAPT
SCHEMBL6467749 0.73 HRH3 (0.39) HRH3STSHSD17B1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040059140-A1 14(15)-unsaturated 15- and/or 16-substituted androgens with mixed androgen-progrestational profile VAN DER LOUW JAPP (NL) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040059140-A1 14(15)-unsaturated 15- and/or 16-substituted androgens with mixed androgen-progrestational profile HSD17B11, CYP17A1, SHBG HRH3 3211/4885STS 320/4885HSD17B1 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.